Professional Summary
Professional Overview
Lewis Warrington is an experienced Chief Medical Officer with a proven track record of driving strategic medical affairs initiatives and delivering measurable impact within the pharmaceutical industry. With a focus on respiratory, psychiatry, and neurology therapeutic areas, he brings a wealth of expertise in leading global medical affairs teams and collaborating cross-functionally to advance product pipelines and improve patient outcomes.
Experience Summary
Current Role
As the Chief Medical Officer at Ironshore, Lewis is responsible for overseeing the company's global medical affairs strategy and ensuring the clinical and scientific integrity of Ironshore's product portfolio. He collaborates closely with cross-functional teams to support the development and commercialization of innovative therapeutics, while also leading the medical strategy for product life cycle management.
Career Progression
Prior to his current role, Lewis held progressive leadership positions within the medical affairs functions of several prominent pharmaceutical organizations. As the Vice President of Medical Affairs at Ironshore, he was instrumental in shaping the company's global medical strategy and driving the successful launch of multiple products. Earlier in his career, he served as the Strategic Lead for US Medical Affairs at Merck, where he played a pivotal role in the development and implementation of medical affairs strategies for respiratory and CNS therapeutics. Lewis also held senior medical affairs roles at Novartis, sanofi-aventis, and Pfizer, contributing his expertise in the management of respiratory, psychiatry, and neurology therapeutic areas.
Academic Background
Lewis holds a Doctor of Medicine (M.D.) degree, with a focus on internal medicine and clinical research. He has also completed post-graduate training in medical affairs and pharmaceutical leadership, further enhancing his strategic and operational capabilities within the industry.
Areas of Expertise
- Global medical affairs strategy and execution
- Therapeutic area expertise in respiratory, psychiatry, and neurology
- Cross-functional collaboration and stakeholder engagement
- Medical and scientific communication
- Regulatory and compliance oversight
- Clinical development and life cycle management
Professional Impact
Throughout his career, Lewis has been recognized for his ability to drive innovative medical affairs initiatives that have positively impacted the pharmaceutical industry. He has led the successful launch of several products, contributed to the advancement of clinical pipelines, and fostered strong relationships with key opinion leaders, regulatory agencies, and patient advocacy groups. Lewis's strategic vision and collaborative approach have consistently positioned him as a trusted medical affairs leader, respected for his commitment to improving patient care and driving industry progress.
Conclusion
With his comprehensive medical expertise, strategic leadership, and proven track record of success, Lewis Warrington is poised to continue making significant contributions as the Chief Medical Officer at Ironshore. His focus on driving medical affairs excellence, fostering cross-functional collaboration, and delivering measurable impact positions him as a valuable asset in the pharmaceutical industry.
